Kaplan-Meier curves showing outcomes of FL patients with AML by genotype/phenotype p53 status. (A) OS by diagnostic category among patients with mutant TP53. (B) OS by TP53 CN status among patients with 1 TP53 mutation. (C) OS comparison of patients with AML by p53 protein expression patterns detected by immunohistochemistry. (D) OS comparison by immunohistochemistry-based p53 protein expression pattern among patients with any TP53 mutation and intact TP53 CN. NOS, not otherwise specified; RGA, recurrent genetic alteration.